| Bioactivity | rel-Licogliflozin is a relative configuration of Licogliflozin (HY-109092). Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor[1]. |
| CAS | 2730989-98-5 |
| Formula | C23H28O7 |
| Molar Mass | 416.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Monica A. Konerman, et al. Overview of Clinical Treatment Trials for NASH.Curr Hepatol Rep. 2017 Dec;16(4): 366-373. |
rel-Licogliflozin
CAS: 2730989-98-5 F: C23H28O7 W: 416.46
rel-Licogliflozin is a relative configuration of Licogliflozin (HY-109092). Licogliflozin is a sodium glucose cotranspor
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.